Ozempic face emerges as doctors warn against rapid weight loss without clinical plans
Doctors in the United Arab Emirates are reporting a growing number of patients presenting with what is being called “Ozempic face” after rapid weight loss driven by modern weight loss medications, according to local clinicians. The trend, first seen in outpatient clinics over recent months, involves marked facial volume loss and a gaunter appearance that can affect self-image and wellbeing.
Who is affected and what clinicians are seeing
Endocrinologists and dermatologists said the problem is appearing in people who lose fat from the face quickly, particularly those who have used prescription weight loss medications without comprehensive medical oversight. Dr. Furat Wahab, an endocrinology consultant, and Dr. Islam Hamdan, a dermatology specialist, told reporters that older patients, people with long-standing obesity, and those who shed large amounts of weight in a short time are most likely to notice changes.
Meanwhile, mental health specialists caution that the visible change in facial contours can trigger anxiety, lowered self-esteem or disappointment even when major health improvements have occurred. Psychiatrist Dr. Riyadh Khudair noted the psychological impact may be as important as the physical one.
Why Ozempic face develops and key risk factors
Physicians attribute the phenomenon to loss of subcutaneous facial fat and reduced skin elasticity when weight falls quickly. Rapid reduction of adipose tissue under the skin can reveal deeper contours around the cheeks, eyes and jawline, producing hollowing and sagging.
Clinicians list multiple contributing factors: rapid weight loss, long-term prior obesity, unsupervised use of weight loss medications, abrupt dose increases, reliance on drugs alone without lifestyle changes, inadequate nutrition especially protein deficiency, lack of resistance exercise, smoking, poor hydration, and irregular medical follow-up. The report indicates that these elements often interact to increase the likelihood of notable facial changes.
Safe weight loss guidance and integrated treatment steps
Doctors emphasize that a medically supervised, multi-pronged approach reduces the risk of adverse aesthetic and health outcomes. Experts said a safe and sustainable rate of weight loss for most adults is about 0.5 to 1 kilogram per week; this pace gives skin and tissue a better chance to adapt.
Six core measures recommended by specialists include gradual weight reduction, a balanced diet rich in protein, regular physical activity with an emphasis on resistance training, adequate hydration, sufficient sleep, and routine medical monitoring. Therefore, physicians stress that prescription medications should be part of a personalized plan rather than a standalone quick fix.
Treatment options for facial volume loss and timing
Dermatologists report significant advances in non-surgical options to improve skin quality and facial fullness when early intervention is possible. Collagen stimulators, hybrid fillers, botulinum toxin in targeted areas, and radiofrequency devices are among the therapies used to restore volume and tighten skin without surgery.
However, clinicians caution that when skin excess or severe laxity follows massive weight loss, surgical procedures such as facial lifting may be the more appropriate solution. The choice of therapy depends on the degree of fat loss, skin quality, age and individual goals. Early assessment and a staged treatment plan often produce the best outcomes.
Psychological effects and social media influence
Mental health professionals highlight that changes in facial appearance resonate with a person’s identity and social image. Some patients report mixed emotions after successful weight loss, including unexpected distress if their face appears older or gaunter than anticipated.
Experts also warn about the role of social media in amplifying unrealistic expectations. Viral posts frequently spotlight dramatic cases without context about age, baseline weight, or medical supervision. Consequently, individuals may fear seeking necessary obesity treatment or may pursue unsupervised medication use based on incomplete information.
What patients should ask and expect
Healthcare teams advise patients considering prescription weight loss medications to undergo a comprehensive evaluation, discuss realistic outcomes, and receive a written plan that covers nutrition, exercise and scheduled follow-up. Patients should ask about expected rates of weight loss, strategies to preserve muscle and facial volume, and signs that warrant early dermatologic or surgical consultation.
Regulatory perspective and clinical responsibilities
Physicians noted that approval of newer weight loss drugs by national authorities reflects an evolving view of obesity as a chronic disease requiring specialized care. Officials and professional societies emphasize that these medications should be prescribed only after assessment and with monitoring protocols in place to minimise adverse effects, including pronounced facial volume loss.
Clinicians underscored the responsibility of prescribers to set appropriate expectations and integrate lifestyle measures so that health benefits are not overshadowed by preventable aesthetic or psychological harms.
Conclusion and next steps
As use of modern weight loss medications grows, medical teams in the UAE and elsewhere expect to monitor trends in facial changes and other outcomes more closely. Patients and clinicians should watch for guidance from health authorities and professional societies that clarifies best practices for combined drug and lifestyle treatment.
In the short term, experts recommend seeking specialist assessment before starting therapy, following a gradual weight loss plan, and arranging early dermatologic review if facial hollowing appears. Upcoming updates from clinical bodies and longer-term studies will help refine prevention and treatment strategies for Ozempic face and related concerns.
